Candel Therapeutics (CADL) Return on Capital Employed Growth (3y) (2024 - 2025)
Candel Therapeutics (CADL) Return on Capital Employed Growth (3y) (2024 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - | - |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - | -3,782.00 |
| 10 | Candel Therapeutics | 527.20 Mn | 527.20 Mn | - | -223.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -223.00 |
| Sep 30, 2025 | -448.00 |
| Jun 30, 2025 | -539.00 |
| Mar 31, 2025 | -789.00 |
| Dec 31, 2024 | -9,566.00 |
| Sep 30, 2024 | -36,615.00 |